Chika Ogami

419 total citations
18 papers, 306 citations indexed

About

Chika Ogami is a scholar working on Infectious Diseases, Pharmacology and Epidemiology. According to data from OpenAlex, Chika Ogami has authored 18 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 10 papers in Pharmacology and 6 papers in Epidemiology. Recurrent topics in Chika Ogami's work include Antimicrobial Resistance in Staphylococcus (10 papers), Antibiotics Pharmacokinetics and Efficacy (10 papers) and Antibiotic Resistance in Bacteria (3 papers). Chika Ogami is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (10 papers), Antibiotics Pharmacokinetics and Efficacy (10 papers) and Antibiotic Resistance in Bacteria (3 papers). Chika Ogami collaborates with scholars based in Japan, New Zealand and United States. Chika Ogami's co-authors include Yasuhiro Tsuji, Hideto To, Yoshihiro Yamamoto, Hidefumi Kasai, Akiko Mizoguchi, Ippei Sakamaki, Hitoshi Kawasuji, Young‐A Heo, Nicholas H. G. Holford and Yoshiaki Matsumoto and has published in prestigious journals such as PLoS ONE, Journal of Pharmaceutical Sciences and British Journal of Clinical Pharmacology.

In The Last Decade

Chika Ogami

18 papers receiving 303 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chika Ogami Japan 10 165 156 69 46 31 18 306
Hidefumi Kasai Japan 12 154 0.9× 145 0.9× 54 0.8× 56 1.2× 47 1.5× 37 350
Lauren M. Hynicka United States 10 105 0.6× 67 0.4× 25 0.4× 114 2.5× 44 1.4× 21 317
Max Taubert Germany 13 87 0.5× 207 1.3× 32 0.5× 93 2.0× 42 1.4× 42 478
Yuki Hanai Japan 11 247 1.5× 179 1.1× 100 1.4× 112 2.4× 21 0.7× 34 384
William Knebel United States 11 280 1.7× 233 1.5× 58 0.8× 161 3.5× 28 0.9× 20 504
Changcheng Shi China 8 236 1.4× 65 0.4× 45 0.7× 96 2.1× 28 0.9× 16 347
Caroline Chen Australia 9 66 0.4× 125 0.8× 22 0.3× 62 1.3× 29 0.9× 16 304
Amirhooshang Mohammadpour Iran 7 205 1.2× 175 1.1× 80 1.2× 64 1.4× 43 1.4× 11 416
Takumi Umemura Japan 10 97 0.6× 56 0.4× 50 0.7× 105 2.3× 49 1.6× 41 273
Scott Van Wart United States 8 158 1.0× 206 1.3× 76 1.1× 119 2.6× 43 1.4× 14 426

Countries citing papers authored by Chika Ogami

Since Specialization
Citations

This map shows the geographic impact of Chika Ogami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chika Ogami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chika Ogami more than expected).

Fields of papers citing papers by Chika Ogami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chika Ogami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chika Ogami. The network helps show where Chika Ogami may publish in the future.

Co-authorship network of co-authors of Chika Ogami

This figure shows the co-authorship network connecting the top 25 collaborators of Chika Ogami. A scholar is included among the top collaborators of Chika Ogami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chika Ogami. Chika Ogami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Yamamoto, Noboru, Shigehisa Kitano, Takafumi Koyama, et al.. (2024). Phase I study of the safety and clinical activity of the interleukin-8 inhibitor AMY109 combined with atezolizumab in patients with advanced solid cancers. Journal for ImmunoTherapy of Cancer. 12(7). e009262–e009262. 3 indexed citations
2.
Ogami, Chika, et al.. (2023). Comparison of the efficacy of anti-diabetic medications as add-on to metformin in type 2 diabetes mellitus from a real-world database. BMC Pharmacology and Toxicology. 24(1). 75–75. 1 indexed citations
3.
Tsuji, Yasuhiro, Nicholas H. G. Holford, Chika Ogami, et al.. (2023). Population Pharmacokinetic Model for Unbound Concentrations of Daptomycin in Patients with MRSA Including Patients Undergoing Hemodialysis. European Journal of Drug Metabolism and Pharmacokinetics. 48(2). 201–211. 1 indexed citations
4.
Tsuji, Yasuhiro, Hidefumi Kasai, Chika Ogami, et al.. (2021). Classification Tree Analysis Based On Machine Learning for Predicting Linezolid-Induced Thrombocytopenia. Journal of Pharmaceutical Sciences. 110(5). 2295–2300. 8 indexed citations
5.
Kawasuji, Hitoshi, Yasuhiro Tsuji, Chika Ogami, et al.. (2021). Proposal of initial and maintenance dosing regimens with linezolid for renal impairment patients. BMC Pharmacology and Toxicology. 22(1). 13–13. 29 indexed citations
6.
Kawasuji, Hitoshi, Makito Kaneda, Akitoshi Ueno, et al.. (2021). A case of COVID-19 diagnosed with favipiravir-induced drug fever based on a positive drug-induced lymphocyte stimulation test. International Journal of Infectious Diseases. 106. 33–35. 7 indexed citations
7.
Ogami, Chika, et al.. (2021). An artificial neural network−pharmacokinetic model and its interpretation using Shapley additive explanations. CPT Pharmacometrics & Systems Pharmacology. 10(7). 760–768. 56 indexed citations
8.
Kawasuji, Hitoshi, Yasuhiro Tsuji, Chika Ogami, et al.. (2021). Initially Reduced Linezolid Dosing Regimen to Prevent Thrombocytopenia in Hemodialysis Patients. Antibiotics. 10(5). 496–496. 9 indexed citations
9.
Nishi, Yoshifumi, Chika Ogami, Yasuhiro Tsuji, et al.. (2020). Evaluation of the relationship between linezolid exposure and hyponatremia. Journal of Infection and Chemotherapy. 27(2). 165–171. 9 indexed citations
10.
Ogami, Chika, Yasuhiro Tsuji, Yoshifumi Nishi, et al.. (2020). External Evaluation of Population Pharmacokinetics and Pharmacodynamics in Linezolid-Induced Thrombocytopenia: The Transferability of Published Models to Different Hospitalized Patients. Therapeutic Drug Monitoring. 43(2). 271–278. 9 indexed citations
11.
Ogami, Chika, Yasuhiro Tsuji, Hideto To, & Yoshihiro Yamamoto. (2019). Pharmacokinetics, toxicity and clinical efficacy of linezolid in Japanese pediatric patients. Journal of Infection and Chemotherapy. 25(12). 979–986. 16 indexed citations
12.
Tsuji, Yasuhiro, et al.. (2019). Effects of a rifampicin pre-treatment on linezolid pharmacokinetics. PLoS ONE. 14(9). e0214037–e0214037. 17 indexed citations
13.
Tsukada, Hiroko, Yasuhiro Tsuji, Yoichi Hiraki, et al.. (2019). Pharmacokinetics and pharmacodynamics of daptomycin in a clinical setting. Journal of Infection and Chemotherapy. 26(2). 230–235. 10 indexed citations
14.
Ogami, Chika, Yasuhiro Tsuji, Yuichi Muraki, et al.. (2019). Population Pharmacokinetics and Pharmacodynamics of Teicoplanin and C‐Reactive Protein in Hospitalized Patients With Gram‐Positive Infections. Clinical Pharmacology in Drug Development. 9(2). 175–188. 16 indexed citations
15.
Tsuji, Yasuhiro, et al.. (2018). Population Pharmacokinetics and Exposure–Response of Lithium Carbonate in Patients Based on Tubular Reabsorption Mechanisms. European Journal of Drug Metabolism and Pharmacokinetics. 44(3). 329–338. 3 indexed citations
16.
Ogami, Chika, Yasuhiro Tsuji, Hidefumi Kasai, et al.. (2017). Evaluation of pharmacokinetics and the stability of daptomycin in serum at various temperatures. International Journal of Infectious Diseases. 57. 38–43. 13 indexed citations
17.
Nakamura, Shigeki, Yasuhiro Tsuji, Chika Ogami, et al.. (2017). Daptomycin-induced Eosinophilic Pneumonia and a Review of the Published Literature. Internal Medicine. 57(2). 253–258. 22 indexed citations
18.
Tsuji, Yasuhiro, Nicholas H. G. Holford, Hidefumi Kasai, et al.. (2017). Population pharmacokinetics and pharmacodynamics of linezolid‐induced thrombocytopenia in hospitalized patients. British Journal of Clinical Pharmacology. 83(8). 1758–1772. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hidefumi Kasai Breakdown of academic impact, for papers by Lauren M. Hynicka Breakdown of academic impact, for papers by Max Taubert Breakdown of academic impact, for papers by Yuki Hanai Breakdown of academic impact, for papers by William Knebel Breakdown of academic impact, for papers by Changcheng Shi Breakdown of academic impact, for papers by Caroline Chen Breakdown of academic impact, for papers by Amirhooshang Mohammadpour Breakdown of academic impact, for papers by Takumi Umemura Breakdown of academic impact, for papers by Scott Van Wart
Rankless by CCL
2026